TechnologiesTechnologiesTechnologiesTechnologies
  • Home
  • Company
    • Our Vision
    • History
    • Current State
    • Contact
  • R&D Projects
    • Anti aging research
    • Mitochondrial transfer technology
    • Anticancer vaccine research
  • Technologies
    • Cancer Immunotherapy
    • Autoimmune and Allergic Disorders Immunotherapy
    • Chronic Inflammatory Diseases Immunotherapy
    • OPI Therapy for Motor and Skin Diseases
    • Storage of Immune Cells
  • R&D Products
    • Cord blood plasma
    • Mesenchymal Stem Cells
    • Exosomes
    • Polyantigenic anticancer vaccine
    • Cell lines
    • Cell-based Products
  • Clinic
  • EU projects
  • News
✕

Technologies

  • Home
  • Technologies

Innovita Research has developed some experimental technologies that can be provided for scientific and other customers. In many cases we can help with the preparation and application of these technologies under customer local governmental rules/requirements.

  • Cancer immunotherapy
  • T-cell immunotherapy (T-cell vaccination) for autoimmune and allergic disorders
  • Adoptive cell-based immunotherapy for chronic inflammatory diseases
  • OPI therapy for motor and skin diseases
  • Storage of immune cells

Related science news

  • Stem Cell scientists engineer “synthetic organizer” cells to improve kidney organoids
    July 13, 2026
  • Epigenetic mapping provides deeper insight into leukaemia
    July 10, 2026
  • Why Skin Longevity Is Becoming the Next Frontier of Cosmetic Science
    June 30, 2026
  • New way to ‘listen’ to mini hearts could transform drug development
    June 29, 2026
  • Gene tied to energy production in brain could lead to new treatment for cognitive disorders
    June 25, 2026
More news.
© 2017 - 2026 Innovita Research | Privacy policy